• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Sequential determination of circulating immune complexes in ovarian tumors].

作者信息

Beaufort F, Auner H, Lahousen M

出版信息

Wien Med Wochenschr. 1986 Jul 15;136(13):317-22.

PMID:3765649
Abstract

We investigated sera from 39 patients with ovarian tumors with regard to the presence of circulating immune complexes, beginning at the time of diagnosis and further on through the course of disease. We were able to demonstrate circulating immune complexes by means of polyethylenglycolprecipitation. About 75% of the patients in the stages FIGO-ov I and FIGO-ov II showed increased values at the time of diagnosis. Following radical surgery they decreased to almost normal so during the time of remission. A relapse was proceeded by an increase up to 8 weeks before being detectable by clinical investigation. The stages FIGO-ov III and IV did not show a comparable correlation, however. Cases with benign cystic ovarian tumors did not show increased values. The precipitation by polyethylenglycol has been revealed to being a suitable screening method for early diagnosis of relapses.

摘要

相似文献

1
[Sequential determination of circulating immune complexes in ovarian tumors].
Wien Med Wochenschr. 1986 Jul 15;136(13):317-22.
2
Acute phase reactants and circulating immune complexes in patients with ovarian carcinoma.卵巢癌患者的急性期反应物与循环免疫复合物
Arch Immunol Ther Exp (Warsz). 1991;39(1-2):41-50.
3
[Cytokeratin tumor markers in ovarian carcinoma: tissue polypeptide specific antigen (TPS) and M3/M21].卵巢癌中的细胞角蛋白肿瘤标志物:组织多肽特异性抗原(TPS)和M3/M21
Wien Klin Wochenschr. 1998 Oct 2;110(18):635-41.
4
Prognostic relevance of soluble interleukin-2 receptors in patients with ovarian tumors.可溶性白细胞介素-2受体在卵巢肿瘤患者中的预后相关性
Anticancer Res. 1999 Jul-Aug;19(4A):2509-11.
5
Relapse and survival in early-stage ovarian cancer.早期卵巢癌的复发与生存
Arch Gynecol Obstet. 2009 Jul;280(1):71-7. doi: 10.1007/s00404-008-0877-z. Epub 2008 Dec 18.
6
The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.伴有非侵袭性种植的卵巢浆液性交界性肿瘤的复发率和总生存率与时间相关。
Am J Surg Pathol. 2006 Nov;30(11):1367-71. doi: 10.1097/01.pas.0000213294.81154.95.
7
[Prognostic value of early normalization of CA 125 during chemotherapy in stages III and IV ovarian tumors].[CA 125在Ⅲ期和Ⅳ期卵巢肿瘤化疗期间早期恢复正常的预后价值]
Bull Cancer. 1997 Jul;84(7):722-8.
8
[Ovarian carcinoma antigen (CA 125) and ovarian cancer (clinical follow-up and prognostic studies)].[卵巢癌抗原(CA 125)与卵巢癌(临床随访及预后研究)]
Orv Hetil. 1993 Apr 25;134(17):915-8.
9
Prognostic significance of p53 expression in advanced-stage ovarian serous borderline tumors.p53表达在晚期卵巢浆液性交界性肿瘤中的预后意义
Clin Cancer Res. 1999 Dec;5(12):4053-8.
10
Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases.保留恶性卵巢生殖细胞肿瘤患者卵巢功能的保守性手术。74例病例回顾。
Cancer. 2000 Jul 15;89(2):391-8.

引用本文的文献

1
Prognostic significance of circulating immune complexes in cancer patients.循环免疫复合物在癌症患者中的预后意义。
Jpn J Cancer Res. 1991 Nov;82(11):1284-91. doi: 10.1111/j.1349-7006.1991.tb01794.x.